Choroid Plexus Organoids With Tight Barrier and CSF Secretion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current 3D culture systems have not successfully replicated the complex architecture of the choroid plexus, nor have they been shown to be functional in generating CSF, limiting the study of drug permeability through the blood-CSF barrier and BBB.
Innovation Solution
A protocol using a combination of WNT pathway activators and BMP signalling pathway activators is employed to generate choroid plexus organoids that exhibit a tight epithelial barrier and secrete CSF-like fluid, characterized by the presence of specific markers and transporters.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current 3D culture systems are used, then ease of manufacture is maintained, but the ability to replicate complex choroid plexus architecture and generate functional CSF is insufficient
Solution Approach 1:
The patent applies preliminary action by pre-differentiating neural stem cells into neuroepithelial cells before organizing them into organoid structures. This preliminary differentiation step ensures that the cells are properly primed to form functional choroid plexus tissue capable of CSF generation, resolving the contradiction between functional reliability and protocol complexity by structuring the differentiation process in advance.
Solution Approach 2:
The patent segments the choroid plexus development process into distinct stages: neural stem cell differentiation, neuroepithelial cell organization, organoid formation, and functional maturation. This segmentation allows each stage to be optimized independently while maintaining overall functional reliability, addressing the contradiction by breaking down the complex protocol into manageable sequential steps.
2Reliability
If simple culture systems are used, then ease of operation is maintained, but the ability to study drug permeability through blood-CSF barrier is limited
Solution Approach 1:
The patent applies parameter changes by optimizing specific culture conditions including serum-free medium composition, growth factor concentrations, and oxygen tension levels. These parameter adjustments enable the development of functional blood-CSF barrier with selective permeability capabilities while maintaining relatively simple culture system operation, resolving the contradiction between functional reliability and ease of operation.
3Manufacturing precision
If complex signaling pathway activation is employed, then manufacturing precision of choroid plexus architecture is improved, but productivity of organoid generation decreases
Solution Approach 1:
The patent applies periodic action by implementing cyclic activation of WNT and BMP signaling pathways at specific time intervals during organoid development. This periodic signaling approach achieves high architectural fidelity of choroid plexus structures while maintaining reasonable productivity by avoiding continuous complex signaling, thus resolving the contradiction between manufacturing precision and productivity.
Data Source
AI summary
Methods and materials relating to cultured choroid plexus organoids comprising: (a) an epithelium comprising a tight epithelial barrier; and/or (b) one or more cysts surrounded by an epithelium, plus other authentic features and markers.